The role of neuropeptides (oxytocin, vasopressin, neuropeptide S) in the development of cognitive impairment in Alzheimer’s disease
Every year, the number of people diagnosed with Alzheimer’s disease is rapidly increasing. Despite numerous studies, it was not possible to select a therapy that would reliably slow down the course of the disease and result in its complete cure. In this case, any consideration of the issue related t...
Gardado en:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Siberian State Medical University (Tomsk)
2024-04-01
|
| Series: | Бюллетень сибирской медицины |
| Assuntos: | |
| Acceso en liña: | https://bulletin.ssmu.ru/jour/article/view/5533 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|